Unlock The Power of Sleep

With 100% passive data collection and analysis, EarlySense InSight+ captures vital signs, motion & sleep data and transforms them into actionable health insights that drive proactive care decisions.

2022 CES Innovation <br>Award Honoree

2022 CES Innovation
Award Honoree

Continuous Oversight. Actionable Insights.

InSight+ pairs continuous overnight vital signs, movement and sleep data with EarlySense AI models that flag subtle shifts in clinical markers to deliver maximized device compliance with actionable insights.

100 %

COMFORTABLE

100 %

CONTINUOUS

100 %

COMPLIANCE

Heart Rate

Keep A Pulse On Variability and Overnight Shifts

Supports ongoing management of chronic cardiac conditions and support clinical attention to heart rate

Respiratory Rate

Analyze Overnight Breathing Patterns

Supports ongoing management of chronic respiratory conditions and support clinical attention to respiratory rate

Motion

Keep Track Of Movement Levels and Bed Exits

Supports understanding and management of an individual’s movement levels and time in bed, and the frequency of bed exits

Transform overnight sleep data into increased health insights.

By pairing vital signs with more than 11 data points related to sleep and overnight behavior, InSight+ delivers insights to support providers in understanding which biometric measures impact overall health and condition management. Things like sleep quality, sleep duration, plus the time it takes to fall asleep and wake up.

Unlock the power of sleep to drive better care decisions.

Watch the video to learn more.

EarlySense InSight+

A Seamless Solution

Using cellular wireless technology, a plug & play hub automatically pairs with our EarlySense Sensor, and automatically extracts heart rate, respiratory rate, movement levels, bed status, and sleep patterns. Wide-band filtering and adaptive algorithms analyze the data and deliver it to the EarlySense cloud using cellular wireless technology, where it can be accessed by healthcare providers through a variety of data integration options. 

Meet Us at CES 2022

EarlySense will be showcasing InSight+ at the Innovation Awards Showcase at CES 2022, as well as participating in the Digital Health portion of the show. We would love to spend time with you. Please reach out to schedule a demo or participate in our podcast series, Vital Insights. 

CES home page logo

Meet With EarlySense at CES 2022

Schedule A Meeting

Email us at [email protected] or Complete the Form Below
REQUEST MORE INFORMATION

Participate in our Vital Insights Podcast

Record a Podcast

Email CESPodcast @ EarlySense.com
LISTEN NOW

Media Relations

Media Inquiries

The EarlySense team will be at CES 2022 in the Palazzo at the Venetian. For all media inquiries, please email [email protected]
EMAIL US

Join Our Clinical Development and Research Program

Organizations, providers and researchers interested in advancing research on remote patient monitoring, telehealth and digital health including contact-free, continuous monitoring can partner with EarlySense to incorporate our sensing technology and data science capabilities into their efforts. Tell us more about your goals and how we can help.

*Works with most commercially available mattresses **This feature is a non-medical function and these statements have not been reviewed and approved by the FDA. The Sleep Summary feature presented on this website as well as the associated information is not intended to be used for treatment or diagnosis and the product has not been assessed by the FDA for this reason. For non-diagnostic use only. This device is being made available by  FDA Emergency Use Authorization (EUA) Guidance published by FDA and is supported by the Secretary of Health and Human Service’s (HHS’s) declaration that circumstances exist to justify the emergency use of medical devices, including alternative devices used as medical devices, due to shortages during the COVID-19 outbreak. The monitoring information provided by the device are adjunctive (supporting) and should not be solely or primarily relied upon to prevent, diagnose, or treat COVID-19 or co-existing conditions.EarlySense InSight is an FDA cleared device that has been modified as ‘InSight at Home’, to allow for home use under an EUA guidance published by the FDA. Some of the changes such as the sleep summary and home use function have not undergone the same type of review as an FDA-cleared device.

EarlySense InSight+